nedosiran
General
Pronunciation:
ned-oh-sir-an
Trade Name(s)
- Rivfloza
Ther. Class.
none assigned
Pharm. Class.
small interfering ribonucleic acid agents
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Nedosiran." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580069/1/nedosiran.
Vallerand AHA, Sanoski CAC. Nedosiran. Davis's Drug Guide. F.A. Davis Company; 2026. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580069/1/nedosiran. Accessed June 26, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Nedosiran. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580069/1/nedosiran
Vallerand AHA, Sanoski CAC. Nedosiran [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 26]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580069/1/nedosiran.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - nedosiran
ID - 3580069
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580069/1/nedosiran
PB - F.A. Davis Company
ET - 20
DB - Nursing Central
DP - Unbound Medicine
ER -

Davis's Drug Guide

